Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 4.21% is 113% above its 5-year average of -31.92%, near the high end of its 5-year range (-241.38%–65.55%).
As of the fiscal period ended Tuesday, March 31, 2026. 83.41% below its 12-month average of 25.35%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
4.21%
NET PROFIT MARGIN AVG TTM
25.35%
NET PROFIT MARGIN AVG 3Y
8.24%
NET PROFIT MARGIN AVG 5Y
-21.44%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-83.41%
CURRENT VS 3Y AVG
-48.98%
CURRENT VS 5Y AVG
+119.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
9.05%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-53.53%
vs the sector median at left
TransMedics Group, Inc.
Market Cap
$2.79B
Net Profit Margin
4.21%
TTM Avg
25.35%
3Y Avg
8.24%
5Y Avg
-21.44%
Market Cap
$2.86B
Net Profit Margin
-17.06%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$1.22B
Net Profit Margin
-7.13%
TTM Avg
-23.45%
3Y Avg
-155.72%
5Y Avg
-114.72%
Market Cap
$470.55M
Net Profit Margin
-81.78%
TTM Avg
-67.34%
3Y Avg
-66.78%
5Y Avg
-66.78%
Market Cap
$15.31M
Net Profit Margin
-134.54%
TTM Avg
-225.74%
3Y Avg
-158.88%
5Y Avg
-132.14%
Market Cap
$7.17B
Net Profit Margin
-0.56%
TTM Avg
7.00%
3Y Avg
-0.29%
5Y Avg
-8.82%
Market Cap
$7.88B
Net Profit Margin
-0.30%
TTM Avg
-1.75%
3Y Avg
-5.71%
5Y Avg
-20.27%
Market Cap
$8.24B
Net Profit Margin
-17.77%
TTM Avg
-60.53%
3Y Avg
-62.93%
5Y Avg
-77.31%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.79B | 4.21% | 25.35% | 8.24% | -21.44% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.86B | -17.06% | -20.12% | -16.95% | -10.04% |
| Teladoc Health, Inc. (TDOC)vs › | $1.22B | -7.13% | -23.45% | -155.72% | -114.72% |
| Shoulder Innovations, Inc. (SI)vs › | $470.55M | -81.78% | -67.34% | -66.78% | -66.78% |
| NRC Health (NRC)vs › | $441.49M | 4.18% | 12.88% | 16.89% | 20.14% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -134.54% | -225.74% | -158.88% | -132.14% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.17B | -0.56% | 7.00% | -0.29% | -8.82% |
| Oscar Health, Inc. (OSCR)vs › | $7.88B | -0.30% | -1.75% | -5.71% | -20.27% |
| Tempus AI, Inc. (TEM)vs › | $8.24B | -17.77% | -60.53% | -62.93% | -77.31% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.99B | 6.52% | -21.22% | -48.94% | 16.61% |
Operating Margin
14.8%
Net Profit Margin
4.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 4.21% |
| 2025-12-31 | 65.55% |
| 2025-09-30 | 16.91% |
| 2025-06-30 | 22.18% |
| 2025-03-31 | 17.89% |
| 2024-12-31 | 5.64% |
| 2024-09-30 | 3.88% |
| 2024-06-30 | 10.67% |
| 2024-03-31 | 12.59% |
| 2023-12-31 | 4.97% |
| 2023-09-30 | -38.27% |
| 2023-06-30 | -1.91% |
| 2023-03-31 | -6.34% |
| 2022-12-31 | -21.42% |
| 2022-09-30 | -28.91% |
| 2022-06-30 | -56.15% |
| 2022-03-31 | -66.51% |
| 2021-12-31 | -131.03% |
| 2021-09-30 | -241.38% |
| 2021-06-30 | -130.56% |
| 2021-03-31 | -112.25% |
| 2020-12-31 | -82.75% |
| 2020-09-30 | -71.75% |
| 2020-06-30 | -250.58% |
| 2020-03-31 | -117.56% |
| 2019-12-31 | -151.51% |
| 2019-09-28 | -114.92% |
| 2019-06-29 | -162.28% |
| 2019-03-30 | -147.46% |
| 2018-12-31 | -215.43% |
| 2018-09-30 | -126.39% |
| 2018-06-30 | -209.78% |
| 2018-03-31 | -194.56% |
| 2017-12-30 | -220.70% |
| 2017-09-30 | -257.42% |
| 2017-07-01 | -257.35% |
| 2017-04-01 | -306.28% |
